← Back to Clinical Trials
Recruiting NCT06628414

NCT06628414 WHITBY: Working Towards Better Healthcare Interventions for Tinnitus: a Brain Stimulation studY

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06628414
Status Recruiting
Phase
Sponsor University of Nottingham
Condition Tinnitus
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-12-01
Primary Completion 2026-09

Trial Parameters

Condition Tinnitus
Sponsor University of Nottingham
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-12-01
Completion 2026-09
Interventions
transcranial Direct Current Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Tinnitus - the awareness of sound without any outside source - affects around 15% of people and can cause anxiety and depression. Treatment options are limited and do not address tinnitus directly (e.g., reduce its loudness). To do that, we must change brain activity causing tinnitus. Low-dose electrical stimulation, using a technique called transcranial Direct Current Stimulation (tDCS), is a promising approach. The technique is safe and easy to administer. Several small studies have tested tDCS for tinnitus showing some benefits. To assess whether these benefits will generalise to other patients, we need to conduct a randomised controlled trial - a large, rigorously controlled experiment based on prior agreed procedures. Clinical trials are expensive and time-consuming to run and thus require meticulous pilot work to establish the most effective treatment regimens and the most sensitive measures of treatment outcome. The current study aims to provide such pilot information for a clinical trial of tDCS treatment of tinnitus. Using a total of 40 patients, we will establish how to best to administer tDCS and measure resulting changes in tinnitus perception and associated brain activity. The current study is a crucial first step towards determining whether or not tDCS can effectively treat tinnitus.

Eligibility Criteria

Inclusion Criteria: * Aged 18 or over * Suffering from subjective idiopathic tinnitus * Sufficient understanding of English to be able to provide informed consent * Able to safely undergo tDCS Exclusion Criteria: * Aged under 18 * Not suffering from tinnitus or suffering from objective tinnitus * Insufficient understanding of English to be able to provide informed consent * Unable to safely undergo tDCS as assessed by tDCS Safety Questionnaire * Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology